Mono- and binuclear Zn2+-β-lactamase. Role of the conserved cysteine in the catalytic mechanism

Raquel Paul-Soto, Rogert Bauer, Jean Marie Frère, Moreno Galleni, Wolfram Meyer-Klaucke, Hans Nolting, Gian Maria Rossolini, Dominique De Seny, Maria Hernandez-Valladares, Michael Zeppezauer, Hans Werner Adolph

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

When expressed by pathogenic bacteria, Zn2+-β-lactamases induce resistance to most β-lactam antibiotics. A possible strategy to fight these bacteria would be a combined therapy with non-toxic inhibitors of Zn2+-β- lactamases together with standard antibiotics. For this purpose, it is important to verify that the inhibitor is effective under all clinical conditions. We have investigated the correlation between the number of zinc ions bound to the Zn2+-β-lactamase from Bacillus cereus and hydrolysis of benzylpenicillin and nitrocefin for the wild type and a mutant where cysteine 168 is replaced by alanine. It is shown that both the mono-Zn2+ (mononuclear) and di-Zn2+ (binuclear) Zn2+-β-lactamases are catalytically active but with different kinetic properties. The mono-Zn2+- β-lactamase requires the conserved cysteine residue for hydrolysis of the β-lactam ring in contrast to the binuclear enzyme where the cysteine residue is not essential. Substrate affinity is not significantly affected by the mutation for the mononuclear enzyme but is decreased for the binuclear enzyme. These results were derived from kinetic studies on two wild types and the mutant enzyme with benzylpenicillin and nitrocefin as substrates. Thus, targeting drug design to modify this residue might represent an efficient strategy, the more so if it also interferes with the formation of the binuclear enzyme.

Original languageEnglish
Pages (from-to)13242-13249
Number of pages8
JournalJournal of Biological Chemistry
Volume274
Issue number19
DOIs
Publication statusPublished - May 7 1999

Fingerprint

Cysteine
Enzymes
Lactams
Penicillin G
Hydrolysis
Bacteria
Bacillus cereus
Anti-Bacterial Agents
Kinetics
Drug Design
Substrates
Alanine
Zinc
Ions
Mutation
nitrocefin
Therapeutics

ASJC Scopus subject areas

  • Biochemistry

Cite this

Paul-Soto, R., Bauer, R., Frère, J. M., Galleni, M., Meyer-Klaucke, W., Nolting, H., ... Adolph, H. W. (1999). Mono- and binuclear Zn2+-β-lactamase. Role of the conserved cysteine in the catalytic mechanism. Journal of Biological Chemistry, 274(19), 13242-13249. https://doi.org/10.1074/jbc.274.19.13242

Mono- and binuclear Zn2+-β-lactamase. Role of the conserved cysteine in the catalytic mechanism. / Paul-Soto, Raquel; Bauer, Rogert; Frère, Jean Marie; Galleni, Moreno; Meyer-Klaucke, Wolfram; Nolting, Hans; Rossolini, Gian Maria; De Seny, Dominique; Hernandez-Valladares, Maria; Zeppezauer, Michael; Adolph, Hans Werner.

In: Journal of Biological Chemistry, Vol. 274, No. 19, 07.05.1999, p. 13242-13249.

Research output: Contribution to journalArticle

Paul-Soto, R, Bauer, R, Frère, JM, Galleni, M, Meyer-Klaucke, W, Nolting, H, Rossolini, GM, De Seny, D, Hernandez-Valladares, M, Zeppezauer, M & Adolph, HW 1999, 'Mono- and binuclear Zn2+-β-lactamase. Role of the conserved cysteine in the catalytic mechanism', Journal of Biological Chemistry, vol. 274, no. 19, pp. 13242-13249. https://doi.org/10.1074/jbc.274.19.13242
Paul-Soto R, Bauer R, Frère JM, Galleni M, Meyer-Klaucke W, Nolting H et al. Mono- and binuclear Zn2+-β-lactamase. Role of the conserved cysteine in the catalytic mechanism. Journal of Biological Chemistry. 1999 May 7;274(19):13242-13249. https://doi.org/10.1074/jbc.274.19.13242
Paul-Soto, Raquel ; Bauer, Rogert ; Frère, Jean Marie ; Galleni, Moreno ; Meyer-Klaucke, Wolfram ; Nolting, Hans ; Rossolini, Gian Maria ; De Seny, Dominique ; Hernandez-Valladares, Maria ; Zeppezauer, Michael ; Adolph, Hans Werner. / Mono- and binuclear Zn2+-β-lactamase. Role of the conserved cysteine in the catalytic mechanism. In: Journal of Biological Chemistry. 1999 ; Vol. 274, No. 19. pp. 13242-13249.
@article{e0d1ba27e9214946b5a359b0f6be7ea1,
title = "Mono- and binuclear Zn2+-β-lactamase. Role of the conserved cysteine in the catalytic mechanism",
abstract = "When expressed by pathogenic bacteria, Zn2+-β-lactamases induce resistance to most β-lactam antibiotics. A possible strategy to fight these bacteria would be a combined therapy with non-toxic inhibitors of Zn2+-β- lactamases together with standard antibiotics. For this purpose, it is important to verify that the inhibitor is effective under all clinical conditions. We have investigated the correlation between the number of zinc ions bound to the Zn2+-β-lactamase from Bacillus cereus and hydrolysis of benzylpenicillin and nitrocefin for the wild type and a mutant where cysteine 168 is replaced by alanine. It is shown that both the mono-Zn2+ (mononuclear) and di-Zn2+ (binuclear) Zn2+-β-lactamases are catalytically active but with different kinetic properties. The mono-Zn2+- β-lactamase requires the conserved cysteine residue for hydrolysis of the β-lactam ring in contrast to the binuclear enzyme where the cysteine residue is not essential. Substrate affinity is not significantly affected by the mutation for the mononuclear enzyme but is decreased for the binuclear enzyme. These results were derived from kinetic studies on two wild types and the mutant enzyme with benzylpenicillin and nitrocefin as substrates. Thus, targeting drug design to modify this residue might represent an efficient strategy, the more so if it also interferes with the formation of the binuclear enzyme.",
author = "Raquel Paul-Soto and Rogert Bauer and Fr{\`e}re, {Jean Marie} and Moreno Galleni and Wolfram Meyer-Klaucke and Hans Nolting and Rossolini, {Gian Maria} and {De Seny}, Dominique and Maria Hernandez-Valladares and Michael Zeppezauer and Adolph, {Hans Werner}",
year = "1999",
month = "5",
day = "7",
doi = "10.1074/jbc.274.19.13242",
language = "English",
volume = "274",
pages = "13242--13249",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "19",

}

TY - JOUR

T1 - Mono- and binuclear Zn2+-β-lactamase. Role of the conserved cysteine in the catalytic mechanism

AU - Paul-Soto, Raquel

AU - Bauer, Rogert

AU - Frère, Jean Marie

AU - Galleni, Moreno

AU - Meyer-Klaucke, Wolfram

AU - Nolting, Hans

AU - Rossolini, Gian Maria

AU - De Seny, Dominique

AU - Hernandez-Valladares, Maria

AU - Zeppezauer, Michael

AU - Adolph, Hans Werner

PY - 1999/5/7

Y1 - 1999/5/7

N2 - When expressed by pathogenic bacteria, Zn2+-β-lactamases induce resistance to most β-lactam antibiotics. A possible strategy to fight these bacteria would be a combined therapy with non-toxic inhibitors of Zn2+-β- lactamases together with standard antibiotics. For this purpose, it is important to verify that the inhibitor is effective under all clinical conditions. We have investigated the correlation between the number of zinc ions bound to the Zn2+-β-lactamase from Bacillus cereus and hydrolysis of benzylpenicillin and nitrocefin for the wild type and a mutant where cysteine 168 is replaced by alanine. It is shown that both the mono-Zn2+ (mononuclear) and di-Zn2+ (binuclear) Zn2+-β-lactamases are catalytically active but with different kinetic properties. The mono-Zn2+- β-lactamase requires the conserved cysteine residue for hydrolysis of the β-lactam ring in contrast to the binuclear enzyme where the cysteine residue is not essential. Substrate affinity is not significantly affected by the mutation for the mononuclear enzyme but is decreased for the binuclear enzyme. These results were derived from kinetic studies on two wild types and the mutant enzyme with benzylpenicillin and nitrocefin as substrates. Thus, targeting drug design to modify this residue might represent an efficient strategy, the more so if it also interferes with the formation of the binuclear enzyme.

AB - When expressed by pathogenic bacteria, Zn2+-β-lactamases induce resistance to most β-lactam antibiotics. A possible strategy to fight these bacteria would be a combined therapy with non-toxic inhibitors of Zn2+-β- lactamases together with standard antibiotics. For this purpose, it is important to verify that the inhibitor is effective under all clinical conditions. We have investigated the correlation between the number of zinc ions bound to the Zn2+-β-lactamase from Bacillus cereus and hydrolysis of benzylpenicillin and nitrocefin for the wild type and a mutant where cysteine 168 is replaced by alanine. It is shown that both the mono-Zn2+ (mononuclear) and di-Zn2+ (binuclear) Zn2+-β-lactamases are catalytically active but with different kinetic properties. The mono-Zn2+- β-lactamase requires the conserved cysteine residue for hydrolysis of the β-lactam ring in contrast to the binuclear enzyme where the cysteine residue is not essential. Substrate affinity is not significantly affected by the mutation for the mononuclear enzyme but is decreased for the binuclear enzyme. These results were derived from kinetic studies on two wild types and the mutant enzyme with benzylpenicillin and nitrocefin as substrates. Thus, targeting drug design to modify this residue might represent an efficient strategy, the more so if it also interferes with the formation of the binuclear enzyme.

UR - http://www.scopus.com/inward/record.url?scp=0033531792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033531792&partnerID=8YFLogxK

U2 - 10.1074/jbc.274.19.13242

DO - 10.1074/jbc.274.19.13242

M3 - Article

C2 - 10224083

AN - SCOPUS:0033531792

VL - 274

SP - 13242

EP - 13249

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 19

ER -